Alzheimer's News
Most Popular Alzheimer's Story
Big pharma sees big payback for Alzheimer's research
Wyeth has devoted more than 350 scientists to 23 separate research projects aimed at treating Alzheimer's. So far, that commitment has cost the giant drug developer more than $450 million. But while... Read more...
Latest Headlines
- July 21, 2009
- April 6, 2009
- March 16, 2009
- February 19, 2009
- January 27, 2009
- January 9, 2009
- January 6, 2009
- December 2, 2008
- August 19, 2008
- August 12, 2008
- June 3, 2008
- January 15, 2008
- November 6, 2007
- October 16, 2007
- September 11, 2007
- July 2, 2007
- June 11, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
